EKNL – Do you have your ticket yet? Key move today setting an XTREME breakout week

EKNL closed another SOLID GREEN session tacking on 8.43% closing at HOD of $0.45 and a 50%+ bounce play since last week’s low volume pull back to support levels. EKNL is now set for a XTREME rally that can see pushing into record levels!

EKNL closing green a 3rd day straight is a definite confirmation of 180 degree reversal to bullish trend. We confirmed a Bullish Harami Cross pattern last week, and is definitely showing it’s brute force today.

Share inventory is super thin, and with major news expected soon it can unleash a major rally that will definitely be the highlight of 2012.

We did it with Fuse Science ( DROP ) last December, and we are determined to do it again with EKNL – that’s why we are committed to continue to profile the HUGE potential of EKNL all month and well into December – if you have not gotten your ticket yet, there is very little time before EKNL starts breaking into record territory once again. With $2 price target at hand, investors can see as much as 500%+ gains just in time for the Holidays!

Clearly the technical chart is in major breakout mode triggered by the Harami Cross Bullish pattern and will be super charged with expected major updates to be unleashed by the company. The potential here is too good to pass up and we continue to add to our position daily for an xtreme breakout to shoot us straight pass our term target price of $2.00.

The best part making EKNL the TOP play of 2012 is an active float of only 5.5 million shares and expected to be reduced with the company’s share buyback program in effect – this will definitely make prices soar much faster and much higher than our 2011 monster 83,000% (DROP )

Of course what really stands EKNL apart from everyone else is the relationships and key connections it has build so far.

Teaming up with iMDhealth.ca network just gave EKNL access to thousands of physician , diabetes education centers and health care providers for diabetics across Canada - practically becoming EKNL’s sales force for the treatment of Nueropathy and the FREMS FDA approved technology.

EKNL released monster news announcing EKO’s Dr. Ziemer of NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.” Dr. Paul Ziemer, world renowned for his expertise in the medical field joined the team at EKNL.

EKNL launched first of many Clinics including recent announcement of launching clinics in the USA. These clinics will start to treat patients with their FDA approved FREMS technology that was also presented at the 13th annual Medical last month!

Also, Dr. Ziemer teamed up with Dr. Snow of Neurometrix, a NASDAQ Listed company (NURO) for exclusive hands on demonstration of their testing unit at the show.

No doubt, these are MONSTER updates that are turning a lot of heads, and institutional investors now eying that multi-dollar target level.

These updates already give EKNL HUGE valuation and potential…

…BUT, IT IS WHAT’S STILL TO BE UNLEASHED BY EKNL THAT WILL NOT ONLY BE MIND ‘BLOWING’ IT WILL PROPEL EKNL PRICES ’SKY HIGH’ AND INTO RECORD TERRITORY